Baschera Dominik, Kingwell Doug, Wren Michael, Zellweger René
Department of Orthopaedics and Trauma Surgery, Royal Perth Hospital, Perth, Western Australia, Australia.
ANZ J Surg. 2014 Oct;84(10):776-80. doi: 10.1111/ans.12669. Epub 2014 May 20.
The Ilizarov external fixator (IEF) is used in the treatment of complicated fractures with severe soft tissue damage. Despite advantages of being minimally invasive and allowing early weight-bearing, the IEF has limitations, including size, treatment duration and crucial pin-site care. Many patients showed enormous resilience despite the devastating effects of their injuries. Our aim was to assess the value of IEF treatment for trauma patients with a focus on their quality of life.
A postal survey was administered to 89 patients treated with an IEF at a level 1 trauma centre between January 2000 and June 2009. An SF-12 health survey was incorporated to measure quality of life. SPSS 18.0 was used for statistical analysis of the data.
The response rate was 73%. The majority of patients (77%) were treated with IEF for primary fractures. The median duration in IEF was 174 days (56-614 days). The SF-12 mean mental component score was 51 (16-66) and the mean physical component score was 38 (16-57) at the time of survey. The mental component score was similar to that of a normal population but the physical component score was markedly below. A total of 96.8% respondents were satisfied with the IEF treatment and 91.7% reported that under the same circumstances they would have the same treatment again.
Patient's quality of life scores correlated directly with their injury severity and pre-existing conditions. They were not negatively affected by IEF treatment itself. High quality of life scores (non-physical) were achieved with IEF treatment.
伊里扎洛夫外固定器（IEF）用于治疗伴有严重软组织损伤的复杂骨折。尽管具有微创和允许早期负重的优点，但IEF也有局限性，包括尺寸、治疗持续时间和关键的针道护理。尽管受伤造成了毁灭性影响，但许多患者表现出了巨大的恢复力。我们的目的是评估IEF治疗对创伤患者的价值，重点关注其生活质量。
对2000年1月至2009年6月期间在一级创伤中心接受IEF治疗的89例患者进行了邮寄调查。纳入SF-12健康调查以测量生活质量。使用SPSS 18.0对数据进行统计分析。
回复率为73%。大多数患者（77%）接受IEF治疗原发性骨折。IEF的中位持续时间为174天（56 - 614天）。调查时，SF-12平均心理成分评分为51（16 - 66），平均身体成分评分为38（16 - 57）。心理成分评分与正常人群相似，但身体成分评分明显低于正常人群。共有96.8%的受访者对IEF治疗满意，91.7%的受访者表示在相同情况下他们会再次接受相同的治疗。
患者的生活质量评分与损伤严重程度和既往状况直接相关。它们未受到IEF治疗本身的负面影响。IEF治疗实现了较高的生活质量评分（非身体方面）。
